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Abstract.  A  eDNA encoding a  unique hyaluronan  re- 
ceptor has been molecularly  cloned from a  ~GTll 
3T3 eDNA expression library.  Immunoblot  analyses of 
cell lysates,  using antibodies  to peptides encoded in 
the eDNA,  specifically react with a  58-kD protein. 
This protein  is regulated by the mutant  H-ras gene in 
cells containing  a metallothionein  promoter H-ras hy- 
brid gene.  Further,  antibodies  to peptide  sequences en- 
coded in the eDNA block the increase  in locomotion 
resulting  from induction of the mutant  H-ras gene in 
this cell line.  In a transblot  assay, the bacterially ex- 
pressed protein binds to biotinylated hyaluronan.  Anti- 
bodies to peptides encoded in the cDNA react in im- 
munoblot assays with the 58- and  52-kD proteins  of a 
novel hyaluronan  receptor complex previously impli- 
cated in cell locomotion.  Furthermore,  antibodies 
specific to the 58- and  52-kD proteins,  which block 
ms-induced  locomotion,  also cross-react with the ex- 
pressed,  encoded protein.  The gene product described 
here appears to be a  new type of hyaluronan  recep- 
tor that  is involved in cell locomotion.  It is named 
RHAMM,  an acronym for receptor for hyaluronan- 
mediated motility. 
T 
HE transforming oncogene H-ras has been reported to 
promote cell locomotion (17), although the regulatory 
mechanisms  remain  unknown.  Several observations 
suggest that when this oncogene promotes locomotion, the 
mechanisms are complex and involve, at least, the release of 
autocrine motility factor(s) (14, 20), growth factors (14), and 
the glycosaminoglycan hyaluronan  (HA) ~ (20,  34).  In par- 
ticular, HA appears to function as an autocrine mechanism 
for stimulating maximal locomotion in ms-transformed cells 
(34). Further, it is also required for the ability of an autocrine 
motility-stimulating factor to promote breast carcinoma cell 
locomotion (20).  We have shown that  HA-promoted,  ras- 
transformed cell locomotion requires the presence of a novel 
hyaluronan receptor complex termed I/ARC (34). This com- 
plex of proteins occurs at the cell surface or is released as 
soluble proteins of 72, 68, 58, and 52 kD (32). The complex 
is tightly regulated in vitro (30) and expressed on the leading 
lamellae and perinuclear region only on rapidly locomoting 
cells (29,  31).  Both polyclonal and monoclonal  antibodies 
(pAbs and mAbs, respectively) prepared against this com- 
plex block cell locomotion regulated by mutant ms (34). In 
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a recent study, we have shown that these blocking mAbs are 
specific to the 58- and 52-kD proteins, that these proteins are 
isoforms of each other, and, further, that these proteins are 
the  HA-binding  component of HARC  (Turley,  E.  A.,  K. 
Home,  and  V.  Cripps,  manuscript  submitted  for  publi- 
cation). 
We have used the blocking antibodies specific to the 58- 
and 52-kD HARC proteins to screen a XGT11 3T3 cDNA ex- 
pression library. We describe here the molecular cloning of 
a eDNA encoding a unique protein that is regulated by mu- 
tant H-ms, that is essential for the locomotion of these ms- 
transformed cells, and that binds to HA. Further, antibodies 
to peptides encoded in the cDNA cross-react with the 58- 
and 52-kD proteins  of HARC,  while conversely blocking 
mAbs to the 58-kD HARC protein cross-react with the ex- 
pressed,  encoded  protein.  This  is  the  first  molecularly 
characterized  protein  identified  as  a  requirement  for  the 
locomotion of ms-transformed cells. Further,  our data sug- 
gest that this novel protein encodes a new HA receptor.  It 
is therefore referred to by the acronym RHAMM for recep- 
tor for HA-mediated motility. 
Materials and Methods 
Antibodies 
pAbs and mAbs to HARC  were  prepared  as  described  previously  (31, 
32, 34). All antibodies were purified by affinity chromatography on HARC- 
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blast locomotion, was originally used to screen the eDNA library,  mAb 
3"1"3-5 is shown here to recognize proteins which occur in two isoforms (58 
and 52 kD) in SDS immunoblots of lysates of ms-transformed fibroblasts 
and has previously been shown to block HA-promoted locomotion of these 
fibroblasts  (34).  Mab 3T3-7,  which was  used for immunofuorescence, 
reacts specifically with the 52-58-kD protein of HARC, as shown here by 
SDS immunoblot analyses,  but does not block HA-promoted locomotion 
(34).  Synthetic peptides  mimicking two  amino acid  sequences  in the 
deduced sequence (peptide I, nucleotide sequence 372-435 [corresponding 
to a portion of the repeated  sequence] and peptide II, nucleotide sequence 
804-864  [Fig.  1]) were produced by the Peptide Analysis Core of the 
University  of Alabama Cancer Center,  Birmingham, AL.  The peptides 
were purified by HPLC and characterized by amino acid composition analy- 
ses. Antibodies to the peptides were raised in rabbits as described (31, 32). 
These antibodies were purified by affinity chromatography on columns of 
the appropriate peptides  coupled to CNBr-activated  Sepharose  and the 
specificity of purified antipeptide antibodies to the respective  peptide was 
confirmed  by dot blot assays.  Preimmune antibodies were obtained from 
each rabbit or mouse before immunization, purified as described above and 
used as controls. 
Cloning and DNA Sequencing 
A 3T3-cDNA library in ~gtll was obtained from Clonetech (Pnlo Alto, CA) 
and initially ~reened with both pAb and mAb (3T3-3) to HARC.  One 
clone, which gave a positive signal upon repeated screening with the anti- 
bodies, had a 1.9-kb insert that was subcloned into pUC18 and M13. A re- 
striction map was constructed using the enzymes (Un. States Biocham. 
Corp., Cleveland, OH) indicated in Fig.  1. Nncleotide sequences were de- 
termined by the dideoxy  chain termination method using Sequenase  I and 
Sequenase II kits (Un. States Biochem. Corp.).  Digestion of the insert with 
Accl yielded  a 0.7 kb fragment which was radiolabr  with a Random 
priming kit (Bcthesda Research Laboratories, Bethesda, MD) and was used 
to rescr~n the cDNA library at high stringency, resulting in the isolation 
of a 2.9-kb insert. The insert was isolated after digestion of the Xphnge with 
EcoR1 and iigated into pUC18 and M13 for sequencing.  Sequence analysis 
and comparisons were conducted using IBI/Puskell sequence analysis soft- 
ware and NBRF database (version 18; reference 4). Additional  homology 
searches were conducted with NBRF (6/90) and EMBL (5/90) using FASTA 
and word search programs in GCG software. 
Locomotion Assays 
A 10I"1/2  cell line containing an inducible EJ-ras metallothionein-neomycin 
hybrid gent (designated  212; reference  26) was used for quantitating the 
effect of both pAb to synthetic peptide and mAb to HARC on cell locomo- 
tion in response to 0.001/~g/ml of HA as previously described (34). Anti- 
bodies (mAb 3T3.5,  1/~g/rnl, or pAb peptide II, 1/~g/ml) were added to 
zinc-induced (24 h) cells for 0.5 h, and then exposed to 0.001/~g/mi of HA 
and filmed for a total of 2 h in the presence of both HA and either of the 
above antibodies. To assess specific  effects of the antibodies,  they were 
preincubated for 1 h at 4~  with 50 ~g of HARC proteins before their addi- 
tion to locomotion assays as above. Addition of these proteins by themselves 
had no effect on cell locomotion (results  not shown).  Data were analyzed 
with a Dynacell program (Carl Zeiss, Inc., Thornwood,  NY) that used Fou- 
rier analysis  of cell locomotion to derive a cell motility  index (17). 
Immunofluorescence of  Live Cells 
Cells were grown on glass covcrslips for 24 h after their subculture so that 
monolayers  were  subconfluent.  Cells  were  then incubated with either 
Ca  ++, Mg++-free Hanks' solution or 0.25%  trypsin in Ca  ++, Mg++-free 
Hanks' solution for 3 rain. Primary antibody (pAb II, nucleotide sequence 
804-864, or rabbit IgG) was then added at 1/xg/ml in defined DMEM to 
cultures and incubated for 2-3 h at 37~  Media was gently aspirated from 
cultures which ware then washed and incubated with rhodamine-labeled 
goat anti-rabbit IgG (Sigma Chem. Co., St. Louis, MO; 1:100 dilution) for 
1 h at room temperature. Cells were washed again, and then lightly fixed 
in freshly made 3 % paraformaldehyde.  Fixed monolayers were viewed on 
both an IM35 microscope (Carl Zeiss, Inc.) equipped with epifluorescence 
and also on a Nikon confocal laser scanning microscope.  For confocai mi- 
croscopy, only the first 3 #m of the culture media-facing surface of cells 
was photographed. 
Immunofluorescence of  Fixed Cells 
Double immunofluorescence  studies  of zinc-indnced 212 cells were per- 
formed as described (30, 31) using mAb 3T3-7 to HARC and pAb to peptide 
II (nucleotide sequence 804-864). Monolayers were fixed in freshly pre- 
pared 3 % paraformaldehyde  for 10 rain, and then incubated with 0.I M gly- 
cine to quench autofluorescence.  Fixed monolayers were washed, and then 
incubated with  1 ~g/mi of the above antibodies overnight at 4~  The 
monolayers were again washed, and then incubated with fluorescein-labeled 
goat anti-mouse IgG (to dete~ mAb 31"3-7) and rhodamine-labeled goat 
anti-rabbit IgG (to detect pAb to paptide I). These were purchased from 
Sigma Chem. Co. and used at 1:1,000-fold dilution. Processed monolayers 
were examined with an IM35 microscope (Carl Zeiss, Inc.) equipped with 
epifluorescence  utilizing nonoverlapping  filters of 510--560 am (for rhoda- 
mine)  and  450-490  nm  (for  fluorescein).  Lack  of bleedthrough was 
confirmed by examination of single immunofluorescence  samples with both 
filters (data not shown). 
SDS Immunoblots 
Immunoblot assays were conducted on isolated soluble HARC proteins (32) 
or cell lysates prepared from H-ras-transfected fibroblasts exposed to either 
zinc sulfate or buffer alone for 24 h. The cells were treated with lysis buffer 
containing 25 mM Tris, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycho- 
ate, 0.15 M NaC1, 1 mM EDTA, and protease inhibitors (32). Proteins were 
fractionated by SDS-PAGE on 12.5% polyacrylamide gels (32) and trans- 
ferred to nitrocellulose membranes 0Bio-Rad Laboratories, Rockville Cen- 
ter, NY). Additional protein binding sites were blocked with 0.5% defatted 
milk in TBS (34) and the membrane was incubated with primary antibodies 
(1/~g IgG/ml of TBS containing 0.5% defatted milk) for 12 h at 4~  on a 
gyratory shaker (Stovall, Greensboro, NC). The mAb to p21 ms (pan. ms- 
10) was purchased from Du Pont Co., W'flmington, DE. The washed mem- 
branes were incubated with HRP-labeled goat IgG as a secondary antibody 
for 20 to 60 rain at room temperature. After washing, the membranes were 
developed with peracid followed by luminol and an enhancer following the 
instructions  of  the  manufacturer  (ECL;  Amersham  Corp.,  Arlington 
Heights,  IL).  The oxiacid  product was detected by immediately exposing 
with Kodak X-Omat Xac-5 film. 
Isolation of  RNA and Northern Assays 
Confluent cultures of ras-transfected cells were exposed to zinc sulfate or 
to buffer alone (34) for 24 h. Total RNA was extracted according to Choy 
et al. (6). 60 ~g of RNA was electrophoresed on 1% agarose gels and trans- 
blotted onto Nytran Nylon membranes. The mRNA transcript for the en- 
coded protein was detected using 32P-labeled 1.7-kb fragment of the eDNA 
that contained the open reading frame. Blots were reprobed with 32p-glyc- 
eraldehyde-3-phosphate  dehydrogenase eDNA to control for RNA loading. 
Expression of  RHAMM in Bacteria 
Oligonucleotide  primers corresponding to the second initiation codon and 
the stop codon were prepared and used to amplify the complete open read- 
ing frame by polymerase chain reaction. The second initiation codon was 
chosen since the size of the protein generated by N-glycanase  digestion of 
the 58-kD protein closely  matched this (Turley, E. A., K. Home, and V. 
Cripps,  manuscript submitted for publication). Polymerase chain reaction 
generated a 1,3-kb DNA fragment which was cloned into the PGEX-2T ex- 
pression vector (22) and transformed into Escherichia coil OM101). Induc- 
tion of protein expression in cultures of transformed  E. coil with 0.2 mM 
isopropyl-fl-D-thiogalactopyranoside  resulted  in the production of an in- 
soluble recombinant glutathionc-S-transfcrase  fusion protein. Insoluble fu- 
sion protein was solubilizod by the addition of 4 M urea, 0.05 M Tris, 1 mM 
EDTA,  1% Triton X-100, pH 8.0, followad by gradual removal of the urea 
by dialysis  into 2 M urea, 0.05 M Tris,  1 mM EDTA,  1% Triton X-I00, 
pH 8.0, and then PBS,  1% Triton X-100, pH 7.4.  Solubilized  fusion pro- 
tein was subsequently purified by affinity chromatography on glutathione- 
agarose  (22). 
HA Binding  Assays 
Lysates (25 ~g) from induced bacteria containing either the parental PGEX- 
2T vector or the PGEX-2T  vector with RHAMM DNA were electropho- 
resed on 10% SDS-PAGE and transblotted onto nitrocellulose membranes. 
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Figure L  Restriction  map and sequence 
of the complete 2.9-kb cDNA clone en- 
coding  the  52-58  HARC  protein(s). 
Blocking  pAbs  and  mAbs  to  HARC 
were  prepared  and  used  to  screen  a 
hgtll  3T3  cDNA  expression  library 
(Clonetech). A restriction map was con- 
structed using the enzymes (Un. States 
Biochem.  Corp.)  indicated  in  the  re- 
striction  map. The open reading frame 
of the  clones  is  boxed.  The  sequenc- 
ing strategy is shown below the cDNA 
clones. Both antibodies  to peptides  en- 
coded  in  the  cDNA  (underlined  se- 
quences) and a radiolabeled ACCI frag- 
ment of the  1.9-kb  insert were used to 
isolate  the  2.9  complete  cDNA.  The 
amino acid sequences are shown above 
the DNA sequences. Two possible ini- 
tiation  codons are indicated  with high- 
lighted letters. Potential N-glycosylation 
sites are marked with asterisks and pos- 
sible  signal  sequences  are  underlined 
with broken lines. The stop codon is in- 
dicated  by  highlighted letters.  The se- 
quence data are available from EMBL/ 
GenBank/DDBJ  under  accession  No. 
X-64550. 
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ization of encoded protein to the sur- 
face  of live  ceils.  To demonstrate 
whether or not encoded protein lo- 
calized to the  cell  surface,  H-ras- 
expressing cell monolayers  were pro- 
cessed with (a) pAb to peptide II. (b) 
As  in  a  but  photographed  with  a 
confocal microscope. (c) Ceils were 
treated  lightly  with  trypsin  before 
staining with primary antibody. (d) 
Ceils  were  incubated with  nonim- 
mune rabbit IgG. Primary antibodies 
were  visualized  with  RITC-conju- 
gated goat anti-rabbit IgG and local- 
ized RHAMM to the  cell  surface. 
Trypsin treatment abolished staining 
and samples incubated with nonim- 
mune sera did not exhibit staining. 
Bars: (a and c) 17.2 ~m; (b) 38/~m; 
(d) 43/~m. 
Nitrocellulose  was blocked by incubating with 5% defatted milk in PBS for 
1 h  followed by incubation in the presence of biotinylated HA  (Turley, 
E. A., K.  Hoare, and V. Cripps, manuscript submitted for publication). 
Nitrocellulose  was washed  for 1 h  in TBS containing 0.05 % Tween and 
bound HA was detected by incubation with streptavidin-HRP  (1:1,000 dilu- 
tion; Sigma Chem. Co.), followed by visualization  with chemiluminescence 
(ECL; Amersham Corp.). 
Results 
Isolation of a cDNA Encoding RHAMM 
A clone containing a 1.9-kb insert was isolated by screening 
a 3T3 cell eDNA expression library in Xgtll with both a mAb 
(designated 3T3-3) and a pAb to HARC. Sequencing of the 
insert revealed an open reading frame corresponding to a 
340-amino acid residue of a  COOH-terminal protein seg- 
ment that did not include an initiation codon (Fig.  1). Addi- 
tional clones coding for the same protein were isolated by 
rescreening the library with a 0.7-kb radiolabeled Aecl re- 
striction fragment of the 1.9-kb eDNA and with pAb to syn- 
thetic peptides mimicking segments of the deduced sequence 
(peptides I and II; Fig. 1). A clone containing a 2.9-kb insert 
was positive in both screenings and was further characterized 
(Fig.  1). Restriction mapping and sequencing of this insert 
demonstrated  that  it  contained  a  complete open  reading 
frame and the original 1.9-kb eDNA sequence in its central 
region (Fig.  1). The sequence was unique and did not bear 
significant homology to other proteins registered in NBRF 
or EMBL data banks or to factors known to be involved in 
ras-regulated  locomotion 04).  Like previously character- 
ized proteins such as p53 (36), it contained two possible ini- 
tiation codons, encoding proteins of either 52.2 or 46.7 kD, 
respectively (Fig.  1). The encoded protein was rich in glu- 
tamic acid, lysine, glutamine, and leucine. It had a Pi of 5.2, 
was hydrophillic, and most of the polypeptide was predicted 
to occur as an alpha helix by Chou-Fasman analyses (5). The 
most notable feature of the deduced sequence was  a  21- 
amino acid stretch (which corresponded to peptide I, under- 
lined in Fig.  1) that was repeated five times near the NH2 
terminus.  The predicted  protein  contained eight  putative 
N-glycosylation  sites, five of  which were concentrated within 
the repeated motif. The protein also contained clusters of 
positively charged amino acids throughout the open reading 
frame. It did not encode a hydrophobic sequence long enough 
to span the plasma membrane and possible signal sequences 
following either initiation codon were weak (Fig.  1). 
The Encoded Protein Occurs at the Cell Surface 
The encoded protein occurred at the cell surface as demon- 
strated by positive immunofluorescent staining for RHAMM 
using live cells (Fig. 2, a, and b).  Further, the majority of 
staining occurred on cell processes and at the media surface 
of cells as demonstrated by optically "sectioning" cells using 
a confocal microscope. Staining using pAb to peptide IIen- 
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induced fibroblasts were performed using (a) mAb 3"1"3-5 which specifically reacted with 52-58-kD proteins of I/ARC and (b) pAb to 
peptide II (nueleotide sequence 804-864).  The mAb was detected with FITC anti-mouse IgG and the pAb was detected with RITC 
anti-rabbit IgG. Both antibodies were strikingly localized in the ruffles and processes of zinc sulfate-induced fibroblasts. Preimmune sera 
showed no immunofluorescence  (data not shown). Bar, 16 #m. 
coded  in  the cDNA  (nucleotide  sequence  804-864)  was 
abolished by light trypsin treatment (Fig. 2 c). Fluorescence- 
activated cell sorter analysis of these cells showed quanti- 
fiable staining providing further evidence of a cell surface lo- 
calization (data not shown). In fixed cells, where lamellae 
were well-preserved, the encoded protein was seen to strik- 
ingly accumulate in the ruffles and processes of H-ras-trans- 
formed cells (Fig. 3). Staining also occurred intraceUularly 
in the perinuclear region (data not shown). This distribution 
is typical of molecules that regulate cell locomotion (1, 14). 
It is further noted that the pAb to peptide I colocalized pre- 
cisely with mAb to the 58-kD HARC protein (Fig. 3). 
Mutant H-ras Gene Regulates Expression 
of  RHAMM 
Zinc sulfate induction of a metallothionein-regulated  mutant 
H-ras gene transfected into 10T1/2 fibroblasts (212 cells; ref- 
erence 26) increased the expression of 58-kD proteins (Fig. 
4 A;  +,  -)  detected by pAb to peptide 1I (nucleotide se- 
quence  804-864,  Fig.  1).  p21  ras proteins  were also in- 
creased upon induction (Fig. 4 B,  +,  -). An mRNA tran- 
script of 5.2 kb was detected using a cDNA probe encoding 
the open reading frame of the 2.9-kb cDNA insert and was 
increased 24 h after zinc induction of p21 H-ras expression 
(Fig. 2 c).  Northern blots were reprobed with glyceralde- 
hyde-3-phosphate  dehydrogenase  cDNA for a loading control 
(Fig. 4D). 
Antibodies to Peptides Encoded in the RHAMM 
cDNA Block Locomotion 
Direct evidence for a role of the encoded protein in H-ras- 
regulated cell locomotion was demonstrated in experiments 
designed to test whether antibodies to the encoded protein 
inhibited cell locomotion. As noted previously (34), induc- 
tion of the mutant H-ras gene with zinc sulfate activated an 
HA-dependent motility mechanism in mutant H-ras-trans- 
fected fibroblasts (Fig. 5). Antibodies to peptide II (nucleo- 
tide sequence 804-864,  Fig.  1) specifically inhibited ras- 
regulated locomotion (Fig. 5). 
Bacterially Expressed RHAMM Binds to HA 
An insert containing the open reading frame from the second 
initiation codon was expressed in bacteria as a glutathione-S- 
transferase fusion protein. The fusion protein was analyzed 
as described in Materials and Methods and separated from 
bacterial proteins by electrophoresis on 12.5 % SDS-PAGE. 
RHAMM was identified with mAb 3T3-5, specific to the 52- 
and 58-kD HARC proteins, on immunoblots as a 75-kD pro- 
tein (Fig. 6).  About 26  kD is due to the presence of the 
glutathione-S-transferase peptide with the remaining 45-50 
kD representative of  the recombinant RHAMM peptide. The 
molecular mass of the recombinant peptide is therefore in 
agreement with that observed for the deglycosylated 58-kD 
protein isolated from fibroblasts (Turley,  E. A., K. Hoare, 
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Figure 4. Expression  of encoded protein is regulated by the mutant 
H-ras oncogene. Cell lysates (,4 and B) were prepared from buffer- 
(-) and zinc sulfate-treated (+) fibroblasts transfected with mutant 
H-ms under the control of a metallothionein  promoter (26). Trans- 
blots from SDS-PAGE  were probed with  (,4) pAb to peptide II 
(nucleotide  sequence 804-864) or (B) RAS-10 antibody.  Protein 
standards  are marked by arrowheads and include,  from the top of 
the gel, phosphorylase b (97.4 kD), BSA (68 kD), and trypsin in- 
hibitor (21.5 kD). Induction of  the mutant H-ms gene increased ex- 
pression of  the encoded protein.  RNA (Cand D) was isolated from 
buffer-  (-)  and zinc sulfate-treated  (+) H-ras-transfected fibro- 
blasts.  RNA was hybridized with a  32P-labeled eDNA fragment 
containing the open reading  frame (C). Blots were reprobed with 
H-glyceraldehyde-3-phosphate  dehydrogenase eDNA to control for 
RNA loading  (D). The induction of the mutant ms gene with zinc 
sulfate increased the expression  of a 5.2-kb mRNA transcript. 
and V. Cripps, manuscript submitted for publication) as well 
as that deduced from the nucleotide sequence.  This protein 
specifically bound  to  biotinylated  HA and  was  competed 
with excess labeled HA (Fig. 6). Bacterial lysates that con- 
tained plasmids without the insert did not bind HA (Fig. 6). 
RHAMM Is Antigenically Related to 
the 58- and 52-kD HARC Proteins 
The encoded protein was shown to be antigenically related 
to the 52-58 kD of HARC (32) which are the HA-binding 
proteins of this complex (Turley,  E.  A., K.  Hoare,  and V. 
Cripps,  manuscript  submitted  for  publication).  Thus,  in 
transblot immunoassays and using purified HARC proteins 
as substrate (Fig. 7 A), PabI cross-reacted with the 58- and 
52-kD proteins  (Fig.  7  C).  The blocking mAb 3T3-5 also 
cross-reacted with these proteins  (Fig.  7  B). 
Discussion 
Oncogenic  transformation  by  both  src  and  activated  ras 
genes have been reported to promote synthesis of HA (21, 
32, 34) and the growth of many human tumors is accompa- 
nied by elevated levels of this glycosaminoglycan in the se- 
rum or in tissue surrounding the tumor (19, 25, 27). Tumor 
TREATMENT 
Figure 5. The encoded protein regulates ms-promoted cell locomo- 
tion.  Mutant H-ras-transfected cells (26) induced with zinc sulfate 
were filmed by video timelapse and analyzed with a Dynacell pro- 
gram (Carl Zelss, Inc.). The effect of  nonimmune sera, mAb 3T3-5 
to HARC and pAb to peptide II (nucleotide  sequence 804-964) on 
HA-promoted  locomotion  was  analyzed.  Both  mAb  3T3-5  to 
HARC and pAb to peptide II inhibited cell locomotion in response 
to HA. This effect was reversed  by the addition  of excess HARC 
proteins.  Nonimmune sera had no effect on locomotion relative to 
controls.  Values represent  the mean +  SEM. n  =  50 cells. 
cells often show increased responsiveness to HA-stimulating 
factors (4,  13) and, recently, the increase in locomotion of 
a  ms-transformed cell line has been shown to be mediated 
by HA (34).  We have isolated  and characterized  a  eDNA 
Figure  6,  Bacterially  ex- 
pressed  RHAMM  binds  to 
biotinylated HA. Lysates from 
induced  bacteria  plasmids 
with either an insert encoding 
RHAMM (lanes A, B, and D) 
or  no  insert  (lane  C)  were 
electrophoresed  on SDS-poly- 
acrylamide gels and transblot- 
ted. Biotinylated  HA was ad- 
ded to the blot in the absence 
(lanes A and C) or presence of 
100-fold excess unlabeled HA 
(lane B). Bound HA was then 
detected  with  streptavidin- 
HRP and visualized with che- 
miluminescence.  Transblots  of bacterial  lysates  containing  the 
insert were also incubated  with monoclonal antibody 3T3-5 (lane 
D) to the 58- and 52-kD HARC proteins.  These results  show that 
HA bound to the expressed protein and binding was competed with 
unlabeled  HA. mAb 3T3-5, which blocks locomotion, specifically 
recognized the expressed  protein. The standards are marked with 
arrowheads and include  ix2 macroglobulin (180 kD); B-galactosi- 
dase (116 kD); fructose-6-phosphate kinase (84 kD); pyruvate ki- 
nase (58 kD); and fumarase (48.5 kD). 
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peptide antibody to the encoded pro- 
tein.  HARC proteins were purified 
from spent culture media, and then 
fractionated  by  SDS-PAGE  and 
transblotted.  HARC proteins were 
visualized  with (lane  A) India ink and 
had molecular masses of 72, 68, 58, 
and 52 kD (arrows).  The 52-58-kD 
proteins  reacted  specifically with 
(lane  B)  mAb  3"1"3-5 (blocker of 
locomotion) to HARC, and (lane C) 
pAb to peptide I (nucleotide  sequence 
372--435).  Molecular mass protein 
standards are marked by arrowheads 
and  include from  the  top  of the 
gel,  myosin (200 kD); phosphor- 
ylase b  (97.4 kD);  BSA  (68  kD); 
ovalbumin (43 kD); and trypsin in- 
hibitor (21.5 kD). 
clone from a XGTI 1 cDNA expression library prepared from 
3T3 ceils that encodes a 48- or 52-kD protein, depending 
upon the initiation codon used. This protein is unique, oc- 
curs on the cell surface, is regulated by the H-ras oncogene, 
and mediates locomotion of ms-transformed cells respond- 
ing to HA. Furthermore, in transblot assays it specifically 
binds to HA. Its unique structure and HA-binding properties 
indicate that it is a new HA receptor. Further, its role in cell 
locomotion predicts that it will play an important role in 
developmental,  disease,  and  repair  processes.  Based  on 
these two functional properties, this protein is referred to as 
RHAMM, an acronym for receptor for HA-mediated motility. 
The encoded protein appears to be identical or related to 
the 58- and 52-kD proteins of an HARC originally isolated 
by one of us (32).  These proteins have been shown to be in- 
volved in locomotion (2, 33, 34) and, recently, to also bind to 
HA (Turley, E. A., K. Hoare, and V. Cripps, manuscript sub- 
mired for publication). Thus, pAb specific to the encoded 
protein cross-reacts with the 52, 58-kD HARC protein. Con- 
versely, a battery of monoclonal antibodies that are specific 
for the 52- and 58-kD HARC proteins cross-react with bac- 
terially expressed RHAMM. These observations, combined 
with (a)  the  ability of the HARC proteins to reverse the 
blocking effect ofpAb specific to the encoded protein on cell 
locomotion (Fig. 5), (b) the precise colocalization of the two 
antigens,  (c)  their  common  regulation  by  the  H-ras  on- 
cogene, and (d) their ability to bind to HA and to mediate 
ras-regulated locomotion provide strong evidence that the 
gene product isolated is identical to the HARC protein. 
The HARC is released into the supernatant media (27) and 
contains several components that can be recovered by HA 
affinity purification, including 72-, 68-, 58-, and 52-kD pro- 
teins (32). Interestingly, the 52-kD HARC protein is not ob- 
served in cell lysates but only in the released form. The cell 
surface form of the complex, which is held together by as 
yet unidentified mechanisms, appears to be transmembrane 
(29).  Ultrastructural  studies  reported  elsewhere  localize 
HARC  (29)  to  the  cell  surface but  the  cDNA  encoding 
RHAMM does not encode a long enough hydrophobic re- 
gion to allow it to span the membrane. Either RHAMM is 
associated with an unidentified transmembrane component 
of,  for  instance,  the  HARC  complex,  or  two  forms  of 
RHAMM exist: a soluble and membrane-associated form. 
The  first prediction would resemble  the organization ob- 
served for some animal lectins (1) and the structure that is 
predicted for an elastin-laminin receptor complex in which 
the laminin and elastin-binding component binds to a trans- 
membrane receptor (18, 35). 
Although the cDNA encoding the 56-kD protein does not 
contain a strong signal sequence, it is dearly located at the 
cell surface, as demonstrated by immunofluorescent staining 
of live cells with antibodies specific to RHAMM. Although 
somewhat unusual, a  similar lack of signal sequence has 
been noted for other cell surface receptors including lym- 
phocyte Fc receptor for IgE (10), transferrin receptor (15), 
liver asialoglycoprotein receptor (9),  and the high-affinity 
laminin receptor (18, 35). It is of  course possible that we have 
cloned a  soluble form of RHAMM and that a  membrane 
form also exists. We will further investigate these possibil- 
ities. 
Previous to this report, several  HA-binding proteins, in- 
cluding  CD44  (3,  23,  24),  hyaluronectin/versican  (11), 
aggrecan (7), and link protein (8,  16) have been described. 
These proteins share a homologous region containing the 
HA  binding  domain  (8).  The  predicted  sequence  of the 
cDNA  reported  here  is  unrelated  to  these  molecularly 
characterized HA-binding proteins and the encoded protein 
therefore likely represents a new type of HA receptor. It is 
perhaps  relevant  that  the  21-amino  acid  repeat  motif 
identified from nucleotide sequence 372-684  (Fig.  1) con- 
tains a series of  amphipathic alpha helices (5). Similar struc- 
tures may be important in the binding of proteins of the clot- 
ting cascade to a related glycosaminoglycan, heparin (12). 
In summary, we have characterized a  novel hyaluronan 
receptor that is directly involved in tumor cell locomotion. 
The regulation of its expression by the ms oncogene predicts 
that it plays an important role in oncogenesis and possibly 
morphogenesis. 
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